Latest Safety News

Group 6 Metals reported steady production at its Dolphin Tungsten Mine in Q1 2025, alongside significant progress in its recapitalisation plan and a strengthened financial position amid a tightening global tungsten market.

HITIQ Limited is pivoting towards grassroots athletes with its upcoming PROTEQT concussion management system, backed by strategic partnerships and fresh funding. The company aims for a cashflow positive future as it prepares for commercial rollout.

Kingsgate Consolidated Ltd delivered a robust March 2025 quarter with a 15% rise in gold production and a 13% reduction in all-in sustaining costs, achieving record margins amid operational and exploration advances.

Asra Minerals has completed a comprehensive target generation exercise at its Leonora Gold Projects, identifying 26 priority drill-ready gold targets and securing regulatory approval to commence drilling in Q2 2025. The company also strengthened its balance sheet with a $3 million placement and asset sale proceeds.

EMU NL's latest quarterly report reveals promising copper exploration parallels with Canada’s Highland Valley mine and renewed gold project interest, alongside significant management changes and a pending shareholder showdown.

Eclipse Metals Ltd reported significant progress in its March 2025 quarter, highlighting new high-grade rare earth mineralisation in Greenland and a strategic uranium project earn-in agreement in Australia.

Noble Helium has postponed its Western margin drilling program and appointed Dennis Donald as Non-Executive Chairman, while actively pursuing refinancing and cost-saving measures to sustain its flagship North Rukwa Project.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

Renascor Resources reports significant engineering advances that increase high-value graphite production by 60%, reduce operating costs, and confirm a safer, eco-friendly purification process.

Kinetiko Energy reports encouraging progress in South African gas exploration, with improved well performance and a drilling optimisation study revealing key production enhancements.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

Geopacific Resources has completed a $40 million entitlement offer to fund a major drilling campaign and an updated Definitive Feasibility Study for its 1.67 million ounce Woodlark Gold Project, positioning the company for significant resource growth and project advancement.